The 2025-26 Budget: Health Care Access and Information

Feb 20, 2025 - The contract also grants other specific oversight mechanisms, such as giving HCAI representation on the partner’s governing board. The agreement extends for a ten‑year period after the first commercial sale of the new product.
https://lao.ca.gov/Publications/Report/4979

The 2025-26 California Spending Plan: Health

Oct 16, 2025 - The 2022-23 budget provided $100  million one-time General Fund to manufacture a biosimilar insulin product. Half of the funds supported a contract with a private partner, and the other half was to help construct a new manufacturing facility in California.
https://lao.ca.gov/Publications/Report/5075

The 2026-27 Budget: Department of Developmental Services

Mar 13, 2026 - While the language of H.R.  1 indicates that states should exempt individuals with an intellectual or developmental disability and their family caregivers from new Medicaid eligibility requirements, the degree to which these exemptions are successfully implemented in California will depend on the administration ’s approach.
https://lao.ca.gov/Publications/Report/5157

Climate Change Impacts Across California - Crosscutting Issues

Apr 5, 2022 - For  instance, while current state regulations require that landlords provide their tenants with heating facilities to maintain a minimum temperature of 70 degrees, there is no comparable requirement for cooling mechanisms to avoid exceeding any maximum threshold, meaning renters could be at greater risk during periods of extreme heat.
https://lao.ca.gov/Publications/Report/4575

The 2025-26 Budget: Medi-Cal Pharmacy Spending

Apr 3, 2025 - In addition to the mandatory federal rebates, the state (through the Department of Health Care Services) negotiates additional rebates with manufacturers. Unlike for federal rebates, drug makers are not required to provide state ‑negotiated supplemental rebates.
https://lao.ca.gov/Publications/Report/5026

Mental Health Services Act: Proposed Bond to Fund Behavioral Health Facilities and Veterans Housing

Aug 17, 2023 - The Governor’s proposed bond uses an appropriate funding mechanism to address a well-documented need for behavioral health facilities and veterans housing—priority areas for the Legislature. These elements of the Governor’s proposal are broadly reasonable.
https://lao.ca.gov/Publications/Report/4790

The 2024-25 Budget: Department of Health Care Access and Information

Feb 27, 2024 - The initiative supports a public-private partnership to develop and manufacture a biosimilar insulin product. The deferred funds originally were intended to support the construction of a manufacturing facility.
https://lao.ca.gov/Publications/Report/4860

The 2023-24 California Spending Plan: Health

Oct 23, 2023 - Previous legislation (Chapter  207 of 2020 [SB  852, Pan]) directed CalHHS to enter into partnerships with private industry to manufacture or distribute affordable generic prescription drugs. Last year ’s budget implemented the first year of this program —known as “CalRx ” —by supporting an insulin manufacturing initiative at HCAI.
https://lao.ca.gov/Publications/Report/4810

The 2021-22 Budget: CalAIM: Equity Considerations

Mar 12, 2021 - Creation of a CalAIM equity reporting mechanism or dashboard could be considered in concert with the Health and Human Services Agency ’s effort to create a dashboard tracking health disparities beyond Medi ‑Cal.
https://lao.ca.gov/Publications/Report/4402

The 2022-23 Budget: Health Care Access and Affordability

Feb 23, 2022 - Second, by July 1, 2023, S B  852 requires the administration to produce a report on the feasibility of directly manufacturing and selling generic drugs. Governor ’s Forthcoming Proposal The Governor has announced a forthcoming proposal for a potential partnership to manufacture insulin.
https://lao.ca.gov/Publications/Report/4560